Beijing, Beijing, China Related Funds
| Fund Name | Location |
| Avenue Venture | India, Maharashtra, Mumbai |
| BroadBand Office | Falls Church, United States, Virginia |
| Fast Forward | California, San Francisco, United States |
| Guide Ventures | Bellevue, United States, Washington |
| Hankyu | Japan, Osaka, Osaka Prefecture |
| Ibtikar Fund | Area A, Palestinian Territory, West Bank |
| iMENA Group | Dubai, United Arab Emirates |
| Jishu Jinbu Touzi | China, Fujian, Hunan |
| Kohoen | Japan, Tokyo |
| Navis Capital Partners | Kuala Lumpur, Malaysia |
| New Age Capital | New York, New York, United States |
| OppenheimerFunds | Colorado, Denver, United States |
| Penguin Random House | Canada, Ontario, Toronto |
| Playlab | Bangkok, Krung Thep, Thailand |
| Pontifax AgTech | California, Santa Monica, United States |
| PrimeSet | - |
| Puck Ventures | - |
| WCB EIT+ | Dolnoslaskie, Poland, Wroclaw |
| Yichang Boyue Investment Management | China, Hubei, Yichang |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Aoli Biotechnology | 29 Jan 2024 | Shenzhen, Guangdong, China | |||
Citryll | $21M | 02 Jul 2020 | North Brabant | ||
Citryll | $17M | 03 Jul 2019 | North Brabant | ||
DNALite Therapeutics | $1M | 08 Aug 2018 | San Francisco, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Aoli Biotechnology | 29 Jan 2024 | Shenzhen, Guangdong, China | |||
Citryll | $21M | 02 Jul 2020 | North Brabant | ||
Citryll | $17M | 03 Jul 2019 | North Brabant | ||
DNALite Therapeutics | $1M | 08 Aug 2018 | San Francisco, California, United States |
